Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06526533
PHASE3

RECOMMEND Platform Trial

Sponsor: Australian and New Zealand Intensive Care Research Centre

View on ClinicalTrials.gov

Summary

The goal of this platform trial is to determine the efficacy, safety and cost-effectiveness of various interventions in patients with acute cardiorespiratory failure requiring extracorporeal membrane oxygenation (ECMO) The main question the platform trial aims to address is to determine the effect of a range of interventions on survival, organ support and resource utilisation to day 28 for hospitalised patients receiving ECMO. Researchers will compare various interventions within multiple platform trial domains to see if the interventions have effects on survival, organ support and resource utilisation for the patient cohort. Participants will be enrolled in accordance with the platform trial's domain structure to answer the research questions.

Official title: Generating New Evidence to Reduce Major Complications to Improve the Safety and Efficacy of ECMO in Severe Cardiac and Respiratory Failure (RECOMMEND)

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

600

Start Date

2025-09

Completion Date

2029-06

Last Updated

2025-05-31

Healthy Volunteers

Yes

Interventions

OTHER

Liberal RBC Transfusion

Liberal transfusion trigger group (patient receives RBC transfusion if Hb \<90g/L).

OTHER

Restrictive RBC Transfusion

Restrictive transfusion trigger group (patient receives RBC transfusion if Hb \<70g/L).

Locations (3)

Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia

St. Vincent's Hospital Sydney

Sydney, New South Wales, Australia

The Alfred Hospital

Melbourne, Victoria, Australia